Maximon

𝐌𝐚𝐱𝐢𝐦𝐨𝐧 𝐚𝐭 𝐛𝐢𝐨:𝐜𝐚𝐩 2026 𝐢𝐧 𝐁𝐞𝐫𝐥𝐢𝐧

From 09–11 June 2026, bio:cap will bring together leaders from life sciences, AI, biotech, diagnostics and investment at CityCube Messe Berlin.

Maximon’s Founding Partner Marc P. Bernegger will be joining a panel discussion alongside Gregoire Biollaz, Aksana Labokha and Dr. Isabelle Schiffer, Ph.D to exchange perspectives on how capital, science and entrepreneurship can come together to turn breakthrough innovation into real-world impact.

At Maximon, we believe the future of longevity will be shaped at the intersection of science and business. Building impactful, science-based and scalable companies requires not only strong research, but also the right venture structures, investors and long-term conviction.

Looking forward to insightful discussions in Berlin on the future of life sciences, AI and health innovation.

📍 bio:cap – Life Science & AI Investival
🗓 09–11 June 2026
📌 CityCube Messe Berlin